Generic Tamiflu: Should developing countries ignore intellectual patents from developed nations? “First India said it would ignore Roche’s patents to make a generic form of Tamiflu and now Taiwan is saying the same thing. In both cases, they make the claim that saving the lives of their citizens is a lot more important than protecting the intellectual property of a foreign company.”
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
Get free updates delivered free to your inbox.
Search thousands of physician, PA, NP, and CRNA jobs now.
Comments are moderated before they are published. Please read the comment policy.
